会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • A METHOD FOR PREDICTING THE STATE OF THE GASTRIC MUCOSA
    • 一种预测胃粘膜状态的方法
    • WO2005085871A1
    • 2005-09-15
    • PCT/FI2005/050061
    • 2005-03-03
    • BIOHIT OYJSARNA, SeppoTIUSANEN, TapaniSUOVANIEMI, Osmo
    • SARNA, SeppoTIUSANEN, TapaniSUOVANIEMI, Osmo
    • G01N33/74
    • G01N33/6893G01N2333/595G01N2333/96477G01N2800/062
    • The present invention is directed to a method for assessing or predicting the state of the gastric mucosa in a subject by determining, in said subject, the probability for the gastric mucosa belonging to at least one gastric mucosa class, the method comprising: measuring, from a sample of said subject, the pepsinogen I (PGI) and gastrin-17 (G-17) analyte concentrations, as well as determining the presence or concentration of a marker for Helicobacter pylori ; entering the data so obtained in a data processing system comprising an operating system, a database and means for transceiving and processing data, the said data processing system being adapted to determine the probability for the gastric mucosa belonging to the at least one gastric mucosa class, based on the data entered as well as on predefined clinical data in the database, the information so generated being indicative of the state of the gastric mucosa in said subject.
    • 本发明涉及通过在所述受试者中确定属于至少一种胃粘膜类别的胃粘膜的概率来评估或预测受试者胃粘膜状态的方法,所述方法包括:从 所述受试者的样品,胃蛋白酶原I(PGI)和胃泌素-17(G-17)分析物浓度,以及确定幽门螺杆菌标记物的存在或浓度; 输入在包括操作系统,数据库和用于收发和处理数据的装置的数据处理系统中获得的数据,所述数据处理系统适于确定属于至少一个胃粘膜类的胃粘膜的概率, 基于输入的数据以及数据库中的预定临床数据,所生成的信息指示所述受试者中胃粘膜的状态。
    • 3. 发明申请
    • METHOD AND SAMPLING KIT FOR ASSESSING THE CONDITION OF THE GASTRIC MUCOSA
    • 用于评估胃肠道状况的方法和采样工具
    • WO2008025877A1
    • 2008-03-06
    • PCT/FI2007/050458
    • 2007-08-28
    • BIOHIT OYJSUOVANIEMI, Osmo
    • SUOVANIEMI, Osmo
    • G01N33/68G01N33/573G01N33/574G01N33/74G01N33/569
    • G01N33/6893G01N2333/96472G01N2469/20G01N2800/062
    • The invention concerns a method for assessing the condition of the gastric mucosa in an individual, which method comprises a) determining the concentration of the biomarkers pepsinogen I (PGI) and pepsinogen II (PGII) in a sample from the said individual, and forming the biomarker ratio PGI/PGII from the concentration values obtained for PGI and PGII, b) comparing the values obtained for PGI and PGI/PGII to the respective cut-off values or reference ranges for said biomarkers, whereby a value for at least one of the markers PGI an d PGI/PGII close to or below the lower limit of its reference range or its cut-off value is indicative of corpus atrophy in said individual. If necessary, the method can be combined with as further step of determining the Helicobacter pylori antibody and gastrin-17 (G-17) concentration in a sample from the said individual.
    • 本发明涉及一种用于评估个体胃粘膜状况的方法,该方法包括:a)测定来自所述个体的样品中生物标志物胃蛋白酶原I(PGI)和胃蛋白酶原II(PGII)的浓度,并形成 从PGI和PGII获得的浓度值的生物标志物比例PGI / PGII,b)将对PGI和PGI / PGII获得的值与所述生物标志物的各个截止值或参考范围进行比较,其中至少一个 标记PGI和PGI / PGII接近或低于其参考范围的下限,或其截止值表示所述个体中的语料库萎缩。 如果需要,该方法可以与确定来自所述个体的样品中幽门螺杆菌抗体和胃泌素-17(G-17)浓度的进一步的步骤组合。
    • 8. 发明申请
    • METHOD FOR DETECTING A RISK OF ACID RELATED DISEASE IN AN INDIVIDUAL
    • 检测个体酸性相关疾病风险的方法
    • WO2004023148A1
    • 2004-03-18
    • PCT/FI2003/000653
    • 2003-09-05
    • BIOHIT OYJSUOVANIEMI, OsmoHÄRKÖNEN, MattiSIPPONEN, Pentti
    • SUOVANIEMI, OsmoHÄRKÖNEN, MattiSIPPONEN, Pentti
    • G01N33/74
    • G01N33/56922G01N33/573G01N2333/205G01N2333/595
    • The present invention is directed to a method for detecting a risk of gastric acid related disease in an individual based on assaying the analytes pepsinogen I, fasting gastrin-17 and a marker for Helicobacter pylori infection (Hp-marker), the method comprising selecting a cut-off value for pepsinogen I, fasting gastrin-17 and the Hp-marker, determining the concentration of pepsinogen I, fasting gastrin-17 and the concentration or presence of a Hp-marker in a sample from said individual, andcomparing the concentrations so determined with the selected cut-off values, whereby a pepsinogen I value at or above its respective cut-off value in combination with a Hp-marker value below its respective cut-off value and a fasting gastrin-17 value at or below its cut-off is indicative of an increased risk of gastric acid-related disease in said individual.
    • 本发明涉及一种基于测定分析物胃蛋白酶原I,空腹胃泌素-17和幽门螺杆菌感染(Hp-标记)的标记物来检测个体胃酸相关疾病风险的方法,所述方法包括选择 胃蛋白酶原I,空腹胃泌素-17和Hp标记的临界值,确定胃蛋白酶原I,空腹胃泌素17的浓度,以及来自所述个体的样品中Hp标记的浓度或存在,并比较浓度 用所选择的截止值确定,其中胃蛋白酶原I值等于或高于其各自的临界值,结合Hp-标记值低于其各自的临界值,以及在其切口处或其下方的空腹胃泌素-17值 -off表明在所述个体中胃酸相关疾病的风险增加。